Conference item : Abstract
Transfusions in people with haematological malignancies – Results of a repeat UK national comparative audit with improvement in practice
- Abstract:
- Red cell and platelet transfusions are essential in the management of people with haematological malignancies and bone marrow failure disorders. Up to 65% of platelet components and 25% of red cell components issued are given to haematology patients, and most are used in the elderly. As the UK population is ageing, with a predicted doubling in people aged 85 years by 2041, only using red cell and platelet transfusion to those likely to benefit is imperative to minimise side effects, limit costs, and maintain the blood supply.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 111.6KB, Terms of use)
-
- Publisher copy:
- 10.1111/vox.12658
Authors
- Publisher:
- Wiley
- Host title:
- Vox Sanguinis
- Journal:
- 35th International Congress of the ISBT More from this journal
- Volume:
- 113
- Issue:
- S1
- Pages:
- P709
- Publication date:
- 2018-05-22
- Acceptance date:
- 2018-05-01
- DOI:
- EISSN:
-
1423-0410
- Subtype:
-
Abstract
- Pubs id:
-
pubs:921524
- UUID:
-
uuid:8456ad73-2d5a-4f41-8a8c-a689d45a214e
- Local pid:
-
pubs:921524
- Source identifiers:
-
921524
- Deposit date:
-
2018-09-25
- ARK identifier:
Terms of use
- Copyright holder:
- Estcourt et al
- Copyright date:
- 2018
- Notes:
- This abstract was presented at the 35th international congress of the ISBT. Copyright © 2018 The Authors Vox Sanguinis © 2018 International Society of Blood Transfusion. This is the accepted manuscript version of the abstract. The final version is available online from Wiley at: https://doi.org/10.1111/vox.12658
If you are the owner of this record, you can report an update to it here: Report update to this record